Loading…
Beta amino acid-modified and fluorescently labelled kisspeptin analogues with potent KISS1R activity
Kisspeptin analogues with improved metabolic stability may represent important ligands in the study of the kisspeptin/KISS1R system and have therapeutic potential. In this paper we assess the activity of known and novel kisspeptin analogues utilising a dual luciferase reporter assay in KISS1R‐transf...
Saved in:
Published in: | Journal of peptide science 2016-06, Vol.22 (6), p.406-414 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Kisspeptin analogues with improved metabolic stability may represent important ligands in the study of the kisspeptin/KISS1R system and have therapeutic potential. In this paper we assess the activity of known and novel kisspeptin analogues utilising a dual luciferase reporter assay in KISS1R‐transfected HEK293T cells. In general terms the results reflect the outcomes of other assay formats and a number of potent agonists were identified among the analogues, including β2‐hTyr‐modified and fluorescently labelled forms. We also showed, by assaying kisspeptin in the presence of protease inhibitors, that proteolysis of kisspeptin activity within the reporter assay itself may diminish the agonist outputs. Copyright © 2016 European Peptide Society and John Wiley & Sons, Ltd.
Known and novel kisspeptin analogues were assayed utilising a dual luciferase reporter assay in KISS1R‐transfected HEK293T cells. β2‐hTyr‐modified and fluorescently labelled analogues were identified as potent KISS1R agonists. Proteolysis may diminish the agonist outputs in the reporter assay. |
---|---|
ISSN: | 1075-2617 1099-1387 |
DOI: | 10.1002/psc.2883 |